ALB · Albemarle Corp
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $1.52B | Six Months Ended June 30, 2026 | — |
|
|
|||
| Avg. Realized Price ($/kg LCE) | $19.53 | Q2 2026 | — |
| Consolidated Leverage Ratio non-GAAP | 0.5 | Twelve Months Ended June 30, 2026 | — |
| Consolidated Windfield-Adjusted EBITDA non-GAAP | $2.03B | Twelve Months Ended June 30, 2026 | — |
| Consolidated Windfield-Adjusted Funded Net Debt non-GAAP | $996.13M | Twelve Months Ended June 30, 2026 | — |
| Free cash flow non-GAAP | $638M | Q2 2026 | — |
| Operating cash flow conversion non-GAAP | 83% | Q2 2026 | — |
| Sales Volume (kT LCE) | 65K | Q2 2026 | — |
| Cost and productivity improvements | $40M | Q1 2026 | — |
| Adjusted diluted loss per share attributable to common shareholders non-GAAP | -$0.53 | Q4 2025 | — |
GAAP → non-GAAP reconciliationGAAP Diluted loss per share attributable to common shareholders -$3.87
+$0.15 Non-operating pension and OPEB items
+$3.19 Non-recurring and other unusual items
= Adjusted diluted loss per share attributable to common shareholders -$0.53
|
|||
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ALB
this stock
Albemarle Corp
|
$15.66B | -5.1% | -4.4% | — | 9.5% |
|
LIN
Linde PLC
|
$218.66B | +12.3% | +3.0% | 30.6 | 1.2% |
|
AIQUF
L Air Liquide SA /Fi
|
$122.12B | +4.3% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$84.62B | +6.6% | +2.1% | 32.2 | 2.6% |
|
ECL
Ecolab Inc.
|
$79.62B | +8.8% | +2.2% | 38.1 | 1.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ALB | +4.6% | +14.3% | -27.4% | +14.1% | -5.1% |
| SPY | -0.4% | +2.6% | +10.7% | +2.7% | +12.5% |
| vs SPY | +5.0% | +11.8% | -38.1% | +11.4% | -17.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.